A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Turning tumour promoting macrophages into an anti-tumour phenotype is an attractive therapeutic strategy. Here, the authors develop a polysaccharide-based structure that mimicks pathogen-associated molecular patterns and, by activating the toll-like receptors on macrophage surface, promotes a safe a...
Main Authors: | Yanxian Feng, Ruoyu Mu, Zhenzhen Wang, Panfei Xing, Junfeng Zhang, Lei Dong, Chunming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10354-2 |
Similar Items
-
A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
by: Daping Xie, et al.
Published: (2022-05-01) -
Toll-like receptor agonists as cancer vaccine adjuvants
by: Donghwan Jeon, et al.
Published: (2024-12-01) -
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
by: Max E. Kirtland, et al.
Published: (2020-11-01) -
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
by: Zhi-Mei Liu, et al.
Published: (2022-09-01) -
Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity
by: Christian Winther Wold, et al.
Published: (2024-02-01)